ATLANTA, Sept. 26, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present at the upcoming Deutsche Bank 31st Annual Leveraged Finance Conference on Tuesday, October 3, 2023. The Company's presentation is scheduled to begin at 10:40 a.m. MST.
A live webcast of the presentation will be accessible through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.
About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.
|
Contacts:
|
|
|
| |
|
|
|
Artivion
|
|
Gilmartin Group LLC
|
|
D. Ashley Lee
|
|
Brian Johnston / Lynn Lewis
|
|
Executive Vice President &
|
|
Phone: 332-895-3222
|
|
Chief Financial Officer
|
|
investors@artivion.com
|
|
Phone: 770-419-3355
|
|
|
| |
|
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-present-at-the-deutsche-bank-31st-annual-leveraged-finance-conference-301938436.html
SOURCE Artivion, Inc.
